Drugs / IVL3004
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05620940 | Sep 2024 → Dec 2025 overdue | alcohol dependence, multiple sclerosis, opiate dependence | Inventage Lab., Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IVL3004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05620940 ↗ |
| Route | Intramuscular | “IM, Single Dose” NCT05620940 ↗ |